Viridian Therapeutics, Inc.\DE - VRDN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.511B
QoQ value delta ($000)
+$283.4M (+12.73%)
Implied price effect (QoQ)
-6.62%
Shares
Total shares
136,579,153
QoQ shares delta
+23,444,059 (+20.72%)
Total shares held by funds (by quarter)

Market chart (VRDN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 217 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 305,029 16,604,740 0.01%
BlackRock, Inc. 157,090 8,551,488 0.0%
Bellevue Group AG 123,665 6,731,909 2.6%
Paradigm Biocapital Advisors LP 123,515 6,723,788 2.31%
Kynam Capital Management, LP 118,557 6,453,877 6.55%
STATE STREET CORP 112,515 6,124,976 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 105,599 5,748,410 0.01%
Fairmount Funds Management LLC 93,520 5,090,928 6.18%
VANGUARD CAPITAL MANAGEMENT LLC 84,076 4,576,860 0.0%
Deep Track Capital, LP 65,998 3,592,740 0.96%
Venrock Adviser, LLC 59,847 3,257,917 1.81%
WELLINGTON MANAGEMENT GROUP LLP 57,468 3,128,362 0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC 50,569 2,752,827 0.0%
GEODE CAPITAL MANAGEMENT, LLC 45,968 2,501,869 0.0%
Avoro Capital Advisors LLC 45,925 2,500,000 0.41%
BAKER BROS. ADVISORS LP 43,776 2,383,025 0.22%
Point72 Asset Management, L.P. 43,283 2,356,208 0.05%
Caligan Partners LP 40,303 2,193,981 1.9%
Novo Holdings A/S 39,219 2,135,000 2.28%
TANG CAPITAL MANAGEMENT LLC 32,930 1,792,626 1.5%
Fisher Asset Management, LLC 32,163 1,750,850 0.01%
Candriam S.C.A. 31,340 1,707,698 0.14%
GOLDMAN SACHS GROUP INC 31,069 1,691,304 0.0%
First Turn Management, LLC 30,677 1,670,000 3.28%
DIMENSIONAL FUND ADVISORS LP 29,607 1,611,521 0.01%